Amgen's (AMGN) Trebananib ESMO Safety Data 'Good' - Leerink Swann
Tweet Send to a Friend
Leerink Swann today maintained a Market Perform rating on Amgen (NASDAQ: AMGN) with a price target of $128.00. Analyst Howard ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE